ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
Avatar

ASCO 2021 Update on IO in NSCLC: Considering Data From the Key Trials

By ecancer FEATURING Luis Raez
By ecancer FEATURING Luis Raez
70 views
September 2, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
ASCO 2021
09:04

2021 ASCO Update on Pancreatic and Hepatobiliary Cancers: Surveying …

ecancer

C. Lima

303 views
07:25

ASCO 2021 Update on IO in NSCLC: Considering Data From the Key Trials

ecancer

L. Raez

70 views
09:55

ASCO 2021 Update on Oncogenesis in NSCLC: Overview of Targeting Path…

ecancer

E. Santos​

341 views
06:24

ASCO 2021 Update on mCRPC: VISION Trial Data on Lutetium-177-PSMA-617

ecancer

M. Morris

39 views
06:47

2021 ASCO Highlights on the Most Recent MDS Trials

ecancer

F. Vargas

14 views
06:20

ASCO 2021 Data on Adjuvant Olaparib for Patients with BRCA1/2-Mutate…

ecancer

Z. Nahleh

36 views
05:38

ASCO 2021 Update on Targeted Therapy in BC: Surveying Data From Key …

ecancer

A. Castrellon

93 views
09:26

2021 ASCO Update From ELARA Study on Adult Patients With R/R FL: Eff…

ecancer

S. Schuster

17 views
28:03

ASCO 2021 Updates From Noteworthy Studies: GYN, H&N, GU, Breast, GI …

ecancer

B. Gyawali

373 views
05:27

ASCO 2021 Update on Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibit…

ecancer

C. Baik

92 views
05:50

ASCO 2021 Update on RAS Wild-Type mCRC: PANAMA Trial Data on Mainten…

ecancer

D. Modest

82 views
07:47

Tislelizumab vs. Chemo in 2L for Advanced ESCC: RATIONALE-302 Safety…

ecancer

J. Ajani

36 views
05:20

ASCO 2021 Update on Pembrolizumab vs. Chemo in MSI-H/dMMR mCRC: Fina…

ecancer

T. André

226 views
08:48

2021 ASCO Update on CROSS vs. Perioperative Chemo in Esophagus and G…

ecancer

J. Reynolds

84 views
14:47

2021 ASCO Updates on FGFR as a Tumour Agnostic Indicator and Its Imp…

ecancer

C. Massard, E. Comperat

31 views
25:53

2021 ASCO Data on mHSPC: Overview of the Most Important Trials

ecancer

K. Fizazi, N. Agarwal, A. Morgans, L. Krabbe

552 views
05:32

ASCO 2021 RCC Roundup: Surveying Data From the Key Studies

ecancer

B. McGregor

34 views
27:02

2021 ASCO Highlights on mCRPC: Latest Developments in Diagnostics & …

ecancer

E. Efstathiou, O. Sartor, F. Saad

73 views
17:44

ASCO 2021 Highlights on PARPi and Other mCRPC Treatments

ecancer

N. Shore, O. Sartor

33 views
06:50

ASCO 2021 Update on Abiraterone Acetate + Prednisone and/or Local RT…

ecancer

K. Fizazi

23 views
07:24

2021 ASCO Update in MIBC Patients: HCRN GU 16-257 Trial Data on Gemc…

ecancer

M. Galsky

29 views
09:48

ASCO 2021 Update on Newly Diagnosed mHSPC: ADT + TAK-700 With ADT + …

ecancer

N. Agarwal

14 views
18:13

ASCO 2021 Update on Precision and Molecular Reporting for mCRPC: Rad…

ecancer

E. Efstathiou

304 views
08:55

ASCO 2021 Data on Acalabrutinib +/- Obinutuzumab vs. Obinutuzumab + …

ecancer

J. Sharman

70 views
08:09

ASCO 2021 Update on Adjuvant Olaparib in High-Risk HER2- EBC With BR…

ecancer

A. Tutt

13 views
06:33

Clinically Sufficient Vitamin D Levels at BC Diagnosis & Survival Ou…

ecancer

S. Yao

11 views
16:44

ASCO 2021 Breast Cancer Roundup on Early & Advanced Setting of BC: S…

ecancer

M. Lambertini

16 views
05:33

2021 ASCO Review on KEYNOTE-564: Pembro vs. Placebo as Post-Nephrect…

ecancer

T. Choueiri

32 views
07:23

2021 ASCO Review on Nivo + Chemo vs. Chemo Alone as Neoadjuvant Trea…

ecancer

J. Spicer

81 views
16:37

2021 ASCO Highlights on Amivantamab + Lazertinib for Osimertinib-Rel…

ecancer

J. Sabari, A. Minchom

26 views
06:05

2021 ASCO Updates on LEAP-004: Lenvatinib + Pembro for Patients with…

ecancer

A. Arance

17 views
37:25

2021 ASCO Updates in Exon 20 Insertions: Targeted Therapies, Novel A…

ecancer

M. Krebs, S. Viteri, S. Gadgeel, B. Chul Cho

67 views
08:57

2021 ASCO Updates on Neoadjuvant IO in NSCLC

ecancer

L. Raez

240 views